Cellebrite DI Ltd. Research and Development Expense
Cellebrite DI Ltd. (CLBT) reported Research and Development Expense of $113.88 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-03-03
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $113.88M 20-F · filed 2026-03-03 | |
| 2025-06-30 | $55.89M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $98.42M 20-F · filed 2026-03-03 | |
| 2024-06-30 | $46.89M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $84.39M 20-F · filed 2026-03-03 | |
| 2023-06-30 | $42.18M 6-K · filed 2024-08-15 | |
| 2022-12-31 | $80.62M 20-F · filed 2025-03-18 | |
| 2022-06-30 | $39.25M 6-K · filed 2023-09-01 | |
| 2021-12-31 | $65.54M 20-F · filed 2024-03-21 | |
| 2021-06-30 | $30.28M 6-K · filed 2022-09-13 | |
| 2020-12-31 | $54.38M 20-F · filed 2023-04-27 | |
| 2019-12-31 | $46.57M 20-F · filed 2022-03-29 |